Chronic, recurrent Lymphocytic Leukemia Active Not Recruiting Phase 1 Trials for Romidepsin (DB06176)

Also known as: Recurrent Chronic Lymphocytic Leukemia

IndicationStatusPhase
DBCOND0112002 (Chronic, recurrent Lymphocytic Leukemia)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01638533Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver DysfunctionTreatment